Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This systematic review and meta-analysis aimed to investigate the effectiveness of carbon ion radiotherapy (CIRT) compared to that of conventional radiotherapy in patients with various types of solid tumors. Materials and Methods: We systematically searched eight electronic databases from inception until August 2022 in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. The comparative effectiveness of the different treatment options was assessed by a random-effects meta-analysis. Results: This review included 34 comparative studies and three treatment groups. Overall, the meta-analysis indicated comparable local control rates between the CIRT and control groups [pooled risk ratio (RR)=1.02, 95% confidence interval (CI) 0.90–1.15]. The local control rate in the CIRT group was higher than that in the photon therapy group, but slightly lower than that in the proton radiation therpy (PRT) group. Additionally, the CIRT group had significantly higher overall survival (OS) (RR=1.19, 95% CI=1.01–1.42) and progression-free survival (PFS) (RR=1.50, 95% CI=1.01–2.21) rates compared to the control group. In the subgroup analysis, survival rates were similar between the CIRT and PRT groups. Conclusion: CIRT was associated with improved toxicity, local tumor control, OS, and PFS compared to conventional treatments. Therefore, CIRT was found to be a safe and effective option for achieving local control in patients with solid tumors.
Abstract
Purpose: This systematic review and meta-analysis aimed to investigate the effectiveness of carbon ion radiotherapy (CIRT) compared to that of conventional radiotherapy in patients with various types of solid tumors. Materials and Methods: We systematically searched eight electronic databases from inception until August 2022 in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. The comparative effectiveness of the different treatment options was assessed by a random-effects meta-analysis. Results: This review included 34 comparative studies and three treatment groups. Overall, the meta-analysis indicated comparable local control rates between the CIRT and control groups [pooled risk ratio (RR)=1.02, 95% confidence interval (CI) 0.90–1.15]. The local control rate in the CIRT group was higher than that in the photon therapy group, but slightly lower than that in the proton radiation therpy (PRT) group. Additionally, the CIRT group had significantly higher overall survival (OS) (RR=1.19, 95% CI=1.01–1.42) and progression-free survival (PFS) (RR=1.50, 95% CI=1.01–2.21) rates compared to the control group. In the subgroup analysis, survival rates were similar between the CIRT and PRT groups. Conclusion: CIRT was associated with improved toxicity, local tumor control, OS, and PFS compared to conventional treatments. Therefore, CIRT was found to be a safe and effective option for achieving local control in patients with solid tumors.
참고문헌 (22)
- Kocarnik JM, "Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019 : a systematic analysis for the global burden of disease study 2019", JAMA Oncol, 8, pp.420~444 (2022)
- Seiwert TY, "The concurrent chemoradiation paradigm--general principles", Nat Clin Pract Oncol, 4, pp.86~100 (2007)
- Durante M, "Charged-particle therapy in cancer : clinical uses and future perspectives", Nat Rev Clin Oncol, 14, pp.483~495 (2017)
- Igaki H, "A systematic review of publications on charged particle therapy for hepatocellular carcinoma", Int J Clin Oncol, 23, pp.423~433 (2018)
- Spychalski P, "Patient specific outcomes of charged particle therapy for hepatocellular carcinoma – A systematic review and quantitative analysis", Radiother Oncol, 132, pp.127~134 (2019)
- Goetz G, "Health technology assessment of carbon-ion beam radiotherapy : a systematic review of clinical effectiveness and safety for 54 oncological indications in 12 tumour regions", Anticancer Res, 39, pp.1635~1650 (2019)
- Higgins JP, "Cochrane handbook for systematic reviews of interventions" (2019), John Wiley & Sons
- Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions : explanation and elaboration", Ann Intern Med, 151, pp.W65~W94 (2009)
- "Methodology: checklists"[URL]
- "Common terminology criteria for adverse events (CTCAE) v.5.0 2017"[URL]
- Li M, "Clinical efficacy and safety of proton and carbon ion radiotherapy for prostate cancer : a systematic review and meta-analysis", Front Oncol, 11, pp.709530~ (2021)
- Combs SE, "Treatment with heavy charged particles : systematic review of clinical data and current clinical(comparative)trials", Acta Oncol, 52, pp.1272~1286 (2013)
- Hwang EJ, "Particle therapy toxicity outcomes : a systematic review", J Med Imaging Radiat Oncol, 64, pp.725~737 (2020)
- Jefferson T, "Hadrontherapy for cancer. An overview of HTA reports and ongoing studies", Recenti Prog Med, 110, pp.566~586 (2019)
- Malouff TD, "Carbon ion therapy : a modern review of an emerging technology", Front Oncol, 10, pp.82~ (2020)
- Lomax AJ, "Charged particle therapy : the physics of interaction", Cancer J, 15, pp.285~291 (2009)
- Kamada T, "Carbon ion radiotherapy in Japan : an assessment of 20 years of clinical experience", Lancet Oncol, 16, pp.e93~e100 (2015)
- Pennington Z, "Systematic review of charged-particle therapy for chordomas and sarcomas of the mobile spine and sacrum", Neurosurg Focus, 50, pp.E17~ (2021)
- Allignet B, "Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review", Acta Oncol, 61, pp.720~729 (2022)
- Hwang EJ, "Particle therapy tumour outcomes : an updated systematic review", J Med Imaging Radiat Oncol, 64, pp.711~724 (2020)
- Zhang W, "Carbon ion radiation therapy for sinonasal malignancies : promising results from 2282 cases from the real world", Cancer Sci, 111, pp.4465~4479 (2020)
- "Particle therapy facilities in clinical operation Information about technical equipment"[URL]